Form D · Other
Ascendant Diagnostics, L.L.C.
Fayetteville, AR · CIK 0001551430
Offering snapshot reported Aug 19, 2013 · SEC filing
- Reported sold
- $798K Offering amount: $1.7M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Aug 15, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 19, 2013 | Initial | $798,084 | No comparison | 9 | SEC filing |
| Jun 4, 2012 | Initial | $250,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-201561
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Aug 19, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| R Calvin Goforth | Director |
| Robert Calvin Goforth | Director |
| Steve Harms | Director |
| Mark Kidd | Executive |
| Omid Moghadam | Director, Executive |
| Cindy Webb | Director |
Issuer details
Industry: Other (See others in industry)
Address:
535 W Research Blvd Suite 135
Fayetteville, AR, 72701
Fayetteville, AR, 72701